198 related articles for article (PubMed ID: 11851332)
1. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
Perkins SJ; Goodship TH
J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
[TBL] [Abstract][Full Text] [Related]
2. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H.
Hellwage J; Jokiranta TS; Friese MA; Wolk TU; Kampen E; Zipfel PF; Meri S
J Immunol; 2002 Dec; 169(12):6935-44. PubMed ID: 12471127
[TBL] [Abstract][Full Text] [Related]
3. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.
Aslam M; Perkins SJ
J Mol Biol; 2001 Jun; 309(5):1117-38. PubMed ID: 11399083
[TBL] [Abstract][Full Text] [Related]
4. Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
Jokiranta TS; Jaakola VP; Lehtinen MJ; Pärepalo M; Meri S; Goldman A
EMBO J; 2006 Apr; 25(8):1784-94. PubMed ID: 16601698
[TBL] [Abstract][Full Text] [Related]
5. The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties.
Okemefuna AI; Gilbert HE; Griggs KM; Ormsby RJ; Gordon DL; Perkins SJ
J Mol Biol; 2008 Jan; 375(1):80-101. PubMed ID: 18005991
[TBL] [Abstract][Full Text] [Related]
6. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
Saunders RE; Goodship TH; Zipfel PF; Perkins SJ
Hum Mutat; 2006 Jan; 27(1):21-30. PubMed ID: 16281287
[TBL] [Abstract][Full Text] [Related]
7. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein.
Giannakis E; Jokiranta TS; Male DA; Ranganathan S; Ormsby RJ; Fischetti VA; Mold C; Gordon DL
Eur J Immunol; 2003 Apr; 33(4):962-9. PubMed ID: 12672062
[TBL] [Abstract][Full Text] [Related]
8. Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions.
Józsi M; Heinen S; Hartmann A; Ostrowicz CW; Hälbich S; Richter H; Kunert A; Licht C; Saunders RE; Perkins SJ; Zipfel PF; Skerka C
J Am Soc Nephrol; 2006 Jan; 17(1):170-7. PubMed ID: 16338962
[TBL] [Abstract][Full Text] [Related]
9. Pinpointing the putative heparin/sialic acid-binding residues in the 'sushi' domain 7 of factor H: a molecular modeling study.
Ranganathan S; Male DA; Ormsby RJ; Giannakis E; Gordon DL
Pac Symp Biocomput; 2000; ():155-67. PubMed ID: 10902165
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H.
Morgan HP; Jiang J; Herbert AP; Kavanagh D; Uhrin D; Barlow PN; Hannan JP
Acta Crystallogr D Biol Crystallogr; 2011 Jul; 67(Pt 7):593-600. PubMed ID: 21697597
[TBL] [Abstract][Full Text] [Related]
11. Localization of the third heparin-binding site in the human complement regulator factor H1.
Ormsby RJ; Jokiranta TS; Duthy TG; Griggs KM; Sadlon TA; Giannakis E; Gordon DL
Mol Immunol; 2006 Apr; 43(10):1624-32. PubMed ID: 16263173
[TBL] [Abstract][Full Text] [Related]
12. Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.
Bhattacharjee A; Lehtinen MJ; Kajander T; Goldman A; Jokiranta TS
Mol Immunol; 2010 May; 47(9):1686-91. PubMed ID: 20378178
[TBL] [Abstract][Full Text] [Related]
13. Identification of the second heparin-binding domain in human complement factor H.
Blackmore TK; Hellwage J; Sadlon TA; Higgs N; Zipfel PF; Ward HM; Gordon DL
J Immunol; 1998 Apr; 160(7):3342-8. PubMed ID: 9531293
[TBL] [Abstract][Full Text] [Related]
14. Multiple ligand binding sites on domain seven of human complement factor H.
Giannakis E; Male DA; Ormsby RJ; Mold C; Jokiranta TS; Ranganathan S; Gordon DL
Int Immunopharmacol; 2001 Mar; 1(3):433-43. PubMed ID: 11367528
[TBL] [Abstract][Full Text] [Related]
15. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.
Duthy TG; Ormsby RJ; Giannakis E; Ogunniyi AD; Stroeher UH; Paton JC; Gordon DL
Infect Immun; 2002 Oct; 70(10):5604-11. PubMed ID: 12228288
[TBL] [Abstract][Full Text] [Related]
16. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.
Ferreira VP; Herbert AP; Cortés C; McKee KA; Blaum BS; Esswein ST; Uhrín D; Barlow PN; Pangburn MK; Kavanagh D
J Immunol; 2009 Jun; 182(11):7009-18. PubMed ID: 19454698
[TBL] [Abstract][Full Text] [Related]
17. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
[TBL] [Abstract][Full Text] [Related]
18. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
[TBL] [Abstract][Full Text] [Related]
19. Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin.
Fernando AN; Furtado PB; Clark SJ; Gilbert HE; Day AJ; Sim RB; Perkins SJ
J Mol Biol; 2007 Apr; 368(2):564-81. PubMed ID: 17362990
[TBL] [Abstract][Full Text] [Related]
20. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
